Hypertriglyceridaemia
Conditions
Interventions
The patients with hypertriglyceridaemia and successful coronary intervention are enrolled. The patients receive DHA+EPA (2g/day) and treat for 12 weeks. If the levels of triglyceride in blood is more
Sponsors
Department of Cardiology, Fukuoka University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who had the levels of fasting triglyceride more than 150 mg/dl. 2.Age is 20 years old or more and gender is male or female. 3.Patinets with successful percutaneous coronary intervention 4.Patients who gave their written informed consent to participate for the present study.
Exclusion criteria
Exclusion criteria: 1.Severe cardiac failure 2.Severe liver dysfunction 3.Severe renal dysfunction 4.Pregnancy or lactation in women 5.Patients with a history of allergy to any component of the study medications 6.Ineligible patients according to the judgment by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in triglyceride levels in blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in pulse wave velocity. Changes in biochemical parameters (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol and fraction of fatty acid. Changes in triglyceride levels in blood(breakfact after 2, 4 and 8 hrs). Adverse effects. Investigate MACE (MI,TLR adnd Death) for 1 year. | — |
Countries
Japan
Contacts
Public ContactShin-ichiro Miura
Fukuoka University Hospital Department of Cardiology
Outcome results
None listed